Search Results - "Danes, Christopher G."
-
1
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival
Published in Cancer research (Chicago, Ill.) (15-04-2009)“…Abstract The ubiquitously expressed 14-3-3 proteins are involved in numerous important cellular functions. The loss of 14-3-3σ is a common event in breast…”
Get full text
Journal Article -
2
14-3-3ζ, Down-regulates p53 in Mammary Epithelial Cells and Confers Luminal Filling
Published in Cancer research (Chicago, Ill.) (15-03-2008)“…Abstract Recent progress in diagnostic tools allows many breast cancers to be detected at an early preinvasive stage. Thus, a better understanding of the…”
Get full text
Journal Article -
3
Functional significance of VEGFR‐2 on ovarian cancer cells
Published in International journal of cancer (01-03-2009)“…Vascular endothelial growth factor receptor (VEGFR) has recently been discovered on ovarian cancer cells, but its functional significance is unknown and is the…”
Get full text
Journal Article -
4
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Published in Clinical cancer research (01-06-2009)“…Purpose: Resistance to platinum chemotherapy remains a significant problem in ovarian carcinoma. Here, we examined the biological mechanisms and therapeutic…”
Get full text
Journal Article -
5
Dual targeting of EphA2 and FAK in ovarian carcinoma
Published in Cancer biology & therapy (01-06-2009)“…EphA2 gene silencing has been shown to result in anti-tumor efficacy. Here we considered whether silencing additional targets downstream of EphA2 would further…”
Get full text
Journal Article -
6
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma
Published in Cancer biology & therapy (15-08-2009)“…Purpose: Metronomic chemotherapy regimens have shown anti-tumor activity by anti-angiogenic mechanisms, however, the efficacy of metronomic topotecan in…”
Get full text
Journal Article -
7
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Published in Clinical cancer research (01-08-2021)Get full text
Journal Article -
8
14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling
Published in Cancer research (Chicago, Ill.) (15-03-2008)“…Recent progress in diagnostic tools allows many breast cancers to be detected at an early preinvasive stage. Thus, a better understanding of the molecular…”
Get full text
Journal Article -
9
14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival
Published in Cancer research (Chicago, Ill.) (15-04-2009)“…The ubiquitously expressed 14-3-3 proteins are involved in numerous important cellular functions. The loss of 14-3-3sigma is a common event in breast cancer;…”
Get full text
Journal Article